Diabetic nephropathy, a common diabetes complication, affects millions globally and requires precise biomarker detection without added surgical risks. Our emphasis on label-free multi-modal imaging removes the need for sample preparation and destruction, allowing analysis of smaller biopsies. This approach offers a comprehensive and accurate assessment of structural and biochemical changes in 2D and 3D, improving our understanding of kidney disease using a single microscopy setup. Crucially, it remains compatible with conventional methods, providing a holistic view without requiring extra tissue availability. Preserving this flexibility allows us to uncover hidden insights by visualizing previously quantified data.
|